{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T05:24:16Z","timestamp":1751520256854,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/19\/N\/NZ5\/00001"],"award-info":[{"award-number":["2015\/19\/N\/NZ5\/00001"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present state of cancer chemotherapy is unsatisfactory. New anticancer drugs that marginally improve the\u00a0survival of patients continue to be developed at an unsustainably high cost. The study aimed to elucidate the effects of insulin (INS), an inexpensive drug with a convincing safety profile, on the susceptibility of colon cancer to chemotherapeutic agents: 5-fluorouracil (FU), oxaliplatin (OXA), irinotecan (IRI), cyclophosphamide (CPA) and docetaxel (DOC). To examine the effects of insulin on cell viability and apoptosis, we performed an <jats:italic>in vitro<\/jats:italic> analysis on colon cancer cell lines Caco-2 and SW480. To verify the results, we performed <jats:italic>in vivo<\/jats:italic> analysis on mice bearing MC38 colon tumors. To assess the underlying mechanism of the therapy, we examined the mRNA expression of pathways related to the signaling downstream of insulin receptors (INSR). Moreover, we performed Western blotting to confirm expression patterns derived from the genetic analysis. For\u00a0the quantification of circulating tumor cells in the peripheral blood, we used the maintrac method. The results of our study show that insulin-pretreated colon cancer cells are significantly more susceptible to commonly used chemotherapeutics. The apoptosis ratio was also enhanced when INS was administered complementary to the examined drugs. The <jats:italic>in vivo<\/jats:italic> study showed that the combination of INS and FU resulted in significant inhibition of tumor growth and reduction of the number of circulating tumor cells. This combination caused a significant downregulation of the key signaling substrates downstream of INSR. The results indicate that the downregulation of PIK3CA (phosphatidylinositol 3-kinase catalytic subunit alpha), which plays a critical role in cell signaling and GRB2 (growth factor receptor-bound protein 2), a regulator of cell proliferation and differentiation may be responsible for the sensitizing effect of INS. These findings were confirmed at protein levels by Western blotting. In conclusion, these results suggest that INS might be potentially applied to clinical use to enhance the therapeutic effectiveness of chemotherapeutic drugs. The findings may become a platform for\u00a0the future development of new and inexpensive strategies for the clinical chemotherapy of tumors.<\/jats:p>","DOI":"10.1038\/s41598-019-53145-x","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T11:03:18Z","timestamp":1573556598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2"],"prefix":"10.1038","volume":"9","author":[{"given":"Siddarth","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"\u0141uc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Pielka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Kumar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-6606","authenticated-orcid":false,"given":"Joanna","family":"Wietrzyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Banach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Gamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Pizon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Zi\u00f3\u0142kowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"53145_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clcc.2014.11.002","volume":"14.1","author":"B Gustavsson","year":"2015","unstructured":"Gustavsson, B. et al. A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer 14.1, 1\u201310 (2015).","journal-title":"Clin Colorectal Cancer"},{"key":"53145_CR2","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","volume":"22","author":"T Hu","year":"2016","unstructured":"Hu, T., Li, Z., Gao, C. & Cho, C. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World Journal of Gastroenterology 22, 6876 (2016).","journal-title":"World Journal of Gastroenterology"},{"key":"53145_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1758834015614530","volume":"8","author":"WA Hammond","year":"2015","unstructured":"Hammond, W. A., Swaika, A. & Mody, K. Pharmacologic resistance in colorectal cancer: a review. Therapeutic Advances in Medical Oncology 8, 57\u201384 (2015).","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"53145_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJMp1400104","volume":"370","author":"S Mailankody","year":"2014","unstructured":"Mailankody, S. & Prasad, V. Comparative Effectiveness Questions in Oncology. New England Journal of Medicine 370, 1478\u20131481 (2014).","journal-title":"New England Journal of Medicine"},{"key":"53145_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/0003-4819-89-1-107","volume":"89","author":"SE Shackney","year":"1978","unstructured":"Shackney, S. E., McCormack, G. W. & Cuchural, G. J. Jr. Growth Rate Patterns of Solid Tumors and Their Relation to Responsiveness to Therapy. Annals of Internal Medicine 89, 107 (1978).","journal-title":"Annals of Internal Medicine"},{"key":"53145_CR6","first-page":"3570","volume":"44","author":"GE Gross","year":"1984","unstructured":"Gross, G. E., Boldt, D. H. & Osborne, C. K. Perturbation by insulin of human breast cancer cell cycle kinetics. Cancer Res. 44, 3570 (1984).","journal-title":"Cancer Res."},{"key":"53145_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak, M. Insulin and insulin-like growth factor signalling in neoplasia. Nature Reviews Cancer 8, 915\u2013928 (2008).","journal-title":"Nature Reviews Cancer"},{"key":"53145_CR8","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/bies.20151","volume":"26","author":"P De Meyts","year":"2004","unstructured":"De Meyts, P. Insulin and its receptor: structure, function and evolution. Bioessays 26, 1351\u20131362 (2004).","journal-title":"Bioessays"},{"key":"53145_CR9","doi-asserted-by":"publisher","first-page":"101042831770290","DOI":"10.1177\/1010428317702901","volume":"39","author":"S Agrawal","year":"2017","unstructured":"Agrawal, S. et al. Insulin-induced enhancement of MCF-7 breast cancer cell response to 5-fluorouracil and cyclophosphamide. Tumor Biology 39, 101042831770290 (2017).","journal-title":"Tumor Biology"},{"key":"53145_CR10","doi-asserted-by":"crossref","unstructured":"Agrawal, S. et al. Insulin and novel thioglycosides exert suppressive effect on human breast and colon carcinoma cells. Oncotarget 8 (2017).","DOI":"10.18632\/oncotarget.23170"},{"key":"53145_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00029330-201409200-00025","volume":"127","author":"Y Yang","year":"2014","unstructured":"Yang, Y., Wen, F. & Dang, L. Insulin enhances apoptosis induced by cisplatin in human esophageal squamous cell carcinoma EC9706 cells related to inhibition of autophagy. Chin Med J 127, 353\u2013358 (2014).","journal-title":"Chin Med J"},{"key":"53145_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1745-7254.2007.00554.x","volume":"28","author":"K Zou","year":"2007","unstructured":"Zou, K., Ju, J. H. & Xie, H. Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells. Acta Pharmacol Sin 28, 721\u2013730 (2007).","journal-title":"Acta Pharmacol Sin"},{"key":"53145_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2003.12.023","volume":"209","author":"A Miglietta","year":"2004","unstructured":"Miglietta, A., Panno, M. L. & Bozzo, F. Insulin can modulate MCF 7 cell response to paclitaxel. Cancer Lett 209, 139\u2013145 (2004).","journal-title":"Cancer Lett"},{"key":"53145_CR14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0277-5379(81)80027-2","volume":"17","author":"O Alabaster","year":"1981","unstructured":"Alabaster, O., Vonderhaar, B. & Shafie, S. Metabolic modification by insulin enhances methotrexate cytotoxicity in MCF-7 human breast cancer cells. Eur J Cancer Clin Oncol 17, 1223\u20131228 (1981).","journal-title":"Eur J Cancer Clin Oncol"},{"key":"53145_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00280-003-0716-7","volume":"53","author":"E Lasalvia-Prisco","year":"2004","unstructured":"Lasalvia-Prisco, E. et al. Insulin induced enhancement of antitumoral response to methotrexate in breast cancer patients. Cancer Chemother Pharmacol 53, 220\u2013224 (2004).","journal-title":"Cancer Chemother Pharmacol"},{"key":"53145_CR16","first-page":"140182","volume":"2012","author":"C Damyanov","year":"2012","unstructured":"Damyanov, C., Gerasimova, D., Maslev, I. & Gavrilov, V. Low-dose chemotherapy with insulin (insulin potentiation therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer. ISRN Urol 2012, 140182 (2012).","journal-title":"ISRN Urol"},{"issue":"6","key":"53145_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.bjc.6690790","volume":"81","author":"NJ De Both","year":"1999","unstructured":"De Both, N. J., Vermey, M., Dinjens, W. N. & Bosman, F. T. A comparative evaluation of various invasion assays testing colon carcinoma cell lines. Br J Cancer 81(6), 934 (1999).","journal-title":"Br J Cancer"},{"key":"53145_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/er.2008-0047","volume":"30","author":"A Belfiore","year":"2009","unstructured":"Belfiore, A., Frasca, F., Pandini, G., Sciacca, L. & Vigneri, R. Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30, 586\u2013623 (2009).","journal-title":"Endocr Rev"},{"key":"53145_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3215","volume":"12","author":"M Pollak","year":"2012","unstructured":"Pollak, M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 12, 159\u2013169 (2012).","journal-title":"Nat Rev Cancer"},{"key":"53145_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/13813450801969715","volume":"114","author":"F Frasca","year":"2008","unstructured":"Frasca, F. et al. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem 114, 23\u201337 (2008).","journal-title":"Arch Physiol Biochem"},{"key":"53145_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.cco.0000198021.99347.b9","volume":"18","author":"Y Samuels","year":"2006","unstructured":"Samuels, Y. & Ericson, K. Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18, 77\u201382 (2006).","journal-title":"Curr Opin Oncol"},{"key":"53145_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song, M. S., Salmena, L. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13, 283\u2013296 (2012).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"53145_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrd4204","volume":"13","author":"DA Fruman","year":"2014","unstructured":"Fruman, D. A. & Rommel, C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov. 13, 140\u201356 (2014).","journal-title":"Nat Rev Drug Discov."},{"key":"53145_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.coph.2015.05.016","volume":"23","author":"TA Yap","year":"2015","unstructured":"Yap, T. A., Bjerke, L., Clarke, P. A. & Workman, P. Drugging PI3K in cancer: refining targets and therapeutic strategies. Curr Opin Pharmacol. 23, 98\u2013107 (2015).","journal-title":"Curr Opin Pharmacol."},{"key":"53145_CR25","doi-asserted-by":"publisher","first-page":"a009191","DOI":"10.1101\/cshperspect.a009191","volume":"6","author":"J Boucher","year":"2014","unstructured":"Boucher, J., Kleinridders, A. & Kahn, C. R. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 6, a009191 (2014).","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"53145_CR26","doi-asserted-by":"publisher","first-page":"1e12","DOI":"10.1158\/1535-7163.MCT-06-0080","volume":"6","author":"D Sachdev","year":"2007","unstructured":"Sachdev, D. & Yee, D. Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol Cancer Ther. 6, 1e12 (2007).","journal-title":"Mol Cancer Ther."},{"key":"53145_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/441423a","volume":"441","author":"A Eccleston","year":"2006","unstructured":"Eccleston, A. & Dhand, R. Signalling in cancer, 05\/25\/print. Nature 441, 423 (2006).","journal-title":"Nature"},{"key":"53145_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1126\/science.8316835","volume":"260","author":"EY Skolnik","year":"1993","unstructured":"Skolnik, E. Y. et al. The function of GRB2 in linking the insulin receptor to ras signaling pathways. Science. 260, 1953\u20131955 (1993).","journal-title":"Science."},{"key":"53145_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbrc.2016.06.006","volume":"476","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. Biochem Biophys Res Commun 476, 607\u2013613 (2016).","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"53145_CR30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/geno.1994.1385","volume":"22","author":"K Huebner","year":"1994","unstructured":"Huebner, K. et al. Chromosome locations of genes encoding human signal transduction adapter proteins, Nck (NCK), Shc (SHC1), and Grb2 (GRB2). Genomics. 22(2), 281\u20137 (1994).","journal-title":"Genomics."},{"key":"53145_CR31","first-page":"1191","volume":"19","author":"GZ Yu","year":"2008","unstructured":"Yu, G. Z. et al. New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma. Oncol Rep. 19, 1191\u20131204 (2008).","journal-title":"Oncol Rep."},{"key":"53145_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.cellsig.2013.03.022","volume":"25","author":"CT Hu","year":"2013","unstructured":"Hu, C. T., Wu, J. R. & Wu, W. S. The role of endosomal signaling triggered by metastatic growth factors in tumor progression. Cell Signal 25, 1539\u201345 (2013).","journal-title":"Cell Signal"},{"key":"53145_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.8178156","volume":"264","author":"I Fath","year":"1994","unstructured":"Fath, I. et al. Cloning of a Grb2 isoform with apoptotic properties. Science 264, 971\u20134 (1994).","journal-title":"Science"},{"key":"53145_CR34","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/annonc\/mdv177","volume":"26.8","author":"J Tie","year":"2015","unstructured":"Tie, J. et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Annals of Oncology 26.8, 1715\u20131722 (2015).","journal-title":"Annals of Oncology"},{"key":"53145_CR35","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1200\/JCO.2007.13.6523","volume":"26","author":"K Pachmann","year":"2008","unstructured":"Pachmann, K. et al. Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse. J Clin Oncol 26, 1208\u20131215 (2008).","journal-title":"J Clin Oncol"},{"key":"53145_CR36","doi-asserted-by":"publisher","first-page":"e0185231","DOI":"10.1371\/journal.pone.0185231","volume":"12","author":"T Fujii","year":"2017","unstructured":"Fujii, T. et al. Androgen receptor expression on circulating tumor cells in metastatic breast cancer. Plos One 12, e0185231 (2017).","journal-title":"Plos One"},{"key":"53145_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/diagnostics8010002","volume":"8","author":"J Kitz","year":"2018","unstructured":"Kitz, J., Lowes, L. E., Goodale, D. & Allan, A. L. Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis. Diagnostics (Basel) 8, 2 (2018).","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"53145_CR38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1515\/CCLM.2005.107","volume":"43","author":"K Pachmann","year":"2005","unstructured":"Pachmann, K. et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med 43(6), 617\u2013627 (2005).","journal-title":"Clin Chem Lab Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53145-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53145-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53145-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:45:36Z","timestamp":1671291936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53145-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53145"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53145-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16647"}}